$AGN's products revenues jumped 112.8% to $3.51Bil. Botox revenue was $605MM for 3Q15 on continued strong performance in both aesthetic and therapeutic indications, and Restasis revenue was $328MM driven by continuing strong promotional efforts. Namenda XR revenue was $215MM as prescriptions and formulary coverage remained stable.
The FBI has awarded $MANT a $220MM, cost-plus-award-fee contract
to provide enterprise IT infrastructure support to the FBI's Criminal Justice
Information Services (CJIS) division. $MANT will provide essential and
mission-critical services to the CJIS portfolio of Justice and Public Safety
Systems, collectively known as Systems of Services (SoS).
Builder $PHM stated that demand environment was generally strong in 1Q17, especially in California, Arizona, Texas, mid-west and Florida. It added that heavy rains during the quarter did not impact demand, but will affect its development timelines.
$ESRX said that over the next three
years the company is going to generate tremendous amount of cash and would plan
to deploy the cash thoughtfully. The company added that the cash generation
that it would be targeting would be something that is in the double digits.